8-K12B/A filed August 10, 2022, 7:59 PM ET ticker QDEL CIK 0001906324

other material confidence high sentiment neutral materiality 0.60

QuidelOrtho reports pro forma combined revenue of $2.4B and net income of $489.9M for H1 2022

QuidelOrtho Corp

Pro forma combined revenue for six months ended July 3, 2022: $2.4B; net income $489.9M; diluted EPS $7.22.
Pro forma combined revenue for year ended Jan 2, 2022: $3.74B; net income $619.1M; diluted EPS $9.08.
Acquisition of Ortho Clinical Diagnostics closed May 27, 2022; total purchase consideration ~$4.3B.
Ortho shareholders received $7.14 cash + 0.1055 shares per Ortho share; $2.5B in stock and $1.75B cash paid.
Preliminary purchase price allocation: $3.13B intangible assets, $2.29B goodwill, $767.5M PP&E.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.